Generic Lenacapavir Manufacturing: SA’s Bold 2027 Strategy

Original Article by Bhekisisa Centre for Health Journalism | 2 December 2025

South Africa aims to begin generic Lenacapavir manufacturing by 2027. Read how the government plans to scale local production.

South Africa aims to begin generic Lenacapavir manufacturing by 2027. Read how the government plans to scale local production.

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here

More Posts

Thembisile Xulu Named New Health Director-General

Dr Thembisile Xulu is the new health Director-General, inheriting a strained department, healthcare-worker shortages and NHI litigation.

Read more...

Gauteng Nurse Shortage Deepens, Threatening NHI Rollout

Gauteng is losing 100 nurses a month and needs R5.7bn to fill a 16,000-post gap. This shortage now flagged as a key risk to the NHI rollout.

Read more...

Medical Schemes Should Be Allowed to Offer Low-Cost Benefit Options

Regulation, not demand, blocks affordable cover: medical schemes should be allowed to offer low-cost benefit options (LCBOs) now.

Read more...